Young-onset lung cancer registry and dedicated care program impact on patient experience
Official title: Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
Run by M.D. Anderson Cancer Center · NCT07220096 · Data updated 2026-11-12
This project will see if enrolling adults under 50 with non-small cell lung cancer in a dedicated care program and peer support networks improves their satisfaction, quality of life, and related outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 25, 2025 |
| Main results expected | May 31, 2029 |
| Study ends | May 31, 2031 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT07220096 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–49 with histologically confirmed non-small cell lung cancer who can complete English-language surveys (alone or with interpreter help) are the ideal candidates.
✕Probably not a fit
Individuals outside the 18–49 age range, with non-NSCLC diagnoses, with cognitive or psychiatric conditions that prevent informed consent or survey completion, or who cannot engage with the program or peer support are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry enrolls adults aged 18–49 with histologically confirmed non-small cell lung cancer to collect survey and clinical data over time. Researchers compare patients enrolled in the Young-Onset Lung Cancer (YOLC) program to others to examine patient satisfaction, quality of life (FACT-LUNG), needs of patients and families, peer support participation, clinical trial enrollment, multidisciplinary consultations, overall survival, and financial impacts. Participation involves completing periodic English-language surveys and providing clinical outcome data, with exclusions for those unable to consent or complete surveys. Data will be used to characterize unmet needs and the association between program enrollment or peer support participation and patient-centered and clinical outcomes.
Why it matters
Potential benefit: If successful, the program could improve patient satisfaction and quality of life for younger adults with lung cancer and inform services to better meet patients' and families' needs.
How similar studies have gone: Related observational programs and patient-navigation or peer-support initiatives in oncology have shown improvements in satisfaction and quality of life, but rigorous evidence specifically in young-onset lung cancer remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than 18 years and under 50 years * Histologic confirmation of NSCLC * Able to complete an English-language survey independently or with the assistance of a native-language interpreter * Pregnant women- may be enrolled due to age range of subjects. (Low risk) Exclusion Criteria: * Medical, psychiatric, cognitive, or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study. * The following special patient population will be excluded from study group: * Individuals who are not yet adults (infants, children, teenagers) * Prisoners * Cognitively-impaired adults
Where it's running
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Eric Singhi, MD — M.D. Anderson Cancer Center
- Study coordinator: Eric Singhi, MD
- Email: eksinghi@mdanderson.org
- Phone: 713-745-2263
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.